Pharming to present at the Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days

LEIDEN, The Netherlands, March 30, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will attend the Guggenheim Healthcare Talks |…